Who are Delfina's decision-makers?
Delfina's visible decision-makers are led by Senan Ebrahim, MD, PhD and Isabel Fulcher, PhD.
- CEO
- Senan Ebrahim, MD, PhD
- CTO/key exec
- Isabel Fulcher, PhD
- Founded
- 2021
- Employees
- Around 70 reported
- HQ
- San Francisco, CA
- Prior exit/Notable
- Clinician-founder leading Delfina's maternal health strategy.
- Senan Ebrahim, MD, PhDFounder and CEOFounderClinician-founder leading Delfina's maternal health strategy.
- Isabel Fulcher, PhDCo-founder and Chief Scientific OfficerFounder/current CSOBiostatistician leading predictive modeling and clinical evidence.
- Delfina clinical operations leadershipClinical operationsCurrent teamRuns care delivery and partner implementation.
Who leads Delfina?
Delfina's leadership combines founder-led product direction with domain specialists in engineering, security, healthcare, fintech, defense, or creative AI depending on the category. The people block on this page lists the primary visible executives and their roles.
Who actually makes buying decisions at Delfina?
For vendor sales, the likely buying committee includes the CEO or COO for strategic spend, the CTO or engineering leader for architecture, security leadership for risk review, finance for budget, and legal or compliance for data and procurement terms. In regulated or defense-heavy categories, compliance, trust, and customer-delivery leaders can be equally decisive.
How is Delfina organized as it scales?
Delfina appears organized around a core product and engineering group, a domain-specific go-to-market team, and implementation or customer-success capacity for enterprise accounts. Recent funding or acquisition status should be read as a signal that process, procurement, and security review are getting more formal.
As of June 2026.Sources:DelfinaDelfina Series ANIH Seed Fund Delfina
Delfina — frequently asked questions
